Nevro Corp. (NVRO): Price and Financial Metrics

NVRO POWR Grades

• Value is the dimension where NVRO ranks best; there it ranks ahead of 67.04% of US stocks.
• NVRO's strongest trending metric is Growth; it's been moving down over the last 177 days.
• NVRO ranks lowest in Momentum; there it ranks in the 9th percentile.

NVRO Stock Summary

• NVRO's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.08 -- higher than only 2.08% of US-listed equities with positive expected earnings growth.
• Over the past twelve months, NVRO has reported earnings growth of -6,340.87%, putting it ahead of merely 0.36% of US stocks in our set.
• In terms of volatility of its share price, NVRO is more volatile than 81.2% of stocks we're observing.
• Stocks that are quantitatively similar to NVRO, based on their financial statements, market capitalization, and price volatility, are ALL, FLR, CLMT, SQSP, and XPOF.
• Visit NVRO's SEC page to see the company's official filings. To visit the company's web site, go to www.nevro.com.

NVRO Valuation Summary

• In comparison to the median Healthcare stock, NVRO's price/sales ratio is 61.11% lower, now standing at 1.4.
• NVRO's price/sales ratio has moved down 20.2 over the prior 109 months.

Below are key valuation metrics over time for NVRO.

NVRO Growth Metrics

Its 2 year revenue growth rate is now at -2.39%.
• The 4 year revenue growth rate now stands at 54.95%.
• Its 2 year cash and equivalents growth rate is now at -63.51%.

NVRO's revenue has moved up $5,026,000 over the prior 33 months.

The table below shows NVRO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	395.281	22.939	-7.941
2022-06-30	388.02	-71.773	-139.524
2022-03-31	386.137	-63.428	-136.124
2021-12-31	386.905	-41.881	-131.36
2021-09-30	393.876	-14.863	-108.355
2021-06-30	409.131	11.835	-68.265

NVRO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• NVRO has a Quality Grade of C, ranking ahead of 65.95% of graded US stocks.
• NVRO's asset turnover comes in at 0.556 -- ranking 79th of 186 Medical Equipment stocks.
• CSII, KRMD, and BIOL are the stocks whose asset turnover ratios are most correlated with NVRO.

The table below shows NVRO's key quality metrics over time.